Cyprotex

Predictive ADME-Tox solutions for enhanced drug safety and success.

by Evotec · Drug Discovery AI

Executive Summary

Cyprotex, an Evotec company, specializes in providing comprehensive ADME-Tox (Absorption, Distribution, Metabolism, Excretion, and Toxicology) solutions crucial for drug discovery and preclinical development. The service suite includes high-quality in vitro and in silico services designed to predict human exposure, clinical efficacy, and toxicological outcomes of drug candidates and chemicals. This predictive capability is vital for enhancing the safety and success rate of new drug compounds. Cyprotex leverages a combination of quality data and advanced modeling and simulation techniques to deliver consistent, cost-efficient, and reliable results. Their offerings are accessible through a new e-Store, allowing registered users to view instant pricing and timelines for a wide range of ADME-Tox services. This streamlined approach facilitates early engagement and smooth collaboration, particularly beneficial for AI-driven drug discovery initiatives. The platform is designed to integrate seamlessly into the drug development process, providing full data traceability via a secure LIMS system and enabling real-time data transfer through an API-driven approach. This ensures that critical ADME-Tox data can be efficiently incorporated into preferred analytics tools, supporting faster timelines, reduced risks, and greater cost efficiency in bringing new therapies to market.

Use Cases

  • Screening drug candidates in early-stage discovery for ADME properties.
  • Predicting human exposure and clinical efficacy of drug compounds.
  • Assessing the toxicological outcomes of drug candidates and chemicals.
  • Supporting AI-driven drug discovery initiatives with predictive ADME-Tox data.
  • Expediting IND-enabling studies and regulatory submissions with robust data packages.

Features

Intelligence

  • Predictive Modeling: Utilizes in silico and in vitro data to predict human exposure, clinical efficacy, and toxicological outcomes.
  • AI Integration: Designed to seamlessly integrate with client's AI drug discovery platforms for enhanced decision-making.

Support

  • Expert Consultation: Direct access to Cyprotex scientific experts for guidance and customized service discussions.

Technical Specifications

Architecture
Integrated LIMS and API-driven data transfer system.
Deployment
SaaS (for e-Store access and data delivery)
API Available
Yes

Pricing

Model
Service-based, project-specific pricing
Starting Price
Contact sales
Target Customer
Mid-Market,Enterprise
Free Trial
No

About Evotec

Evotec is a life science company pioneering drug discovery and development by integrating breakthrough science with AI-driven innovation and advanced technologies. They accelerate the journey from concept to cure, offering drug discovery alliance and development services for the biopharma sector. Evotec partners with pharmaceutical and biotechnology companies, academic institutions, and other healthcare stakeholders globally.

Founded: 1993 · Headquarters: Hamburg, Germany · Employees: 1000+ · Public